Quanterix Corporation Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Quanterix Corporation stock issued during period, value, employee stock purchase plan for the quarter ending 2023-03-31 was $551.00K, a 7.24% decline year-over-year.
- Quanterix Corporation stock issued during period, value, employee stock purchase plan for the quarter ending 2022-12-31 was $0.00.
- Quanterix Corporation stock issued during period, value, employee stock purchase plan for the quarter ending 2022-09-30 was $287.00K, a 47.44% decline year-over-year.
- Quanterix Corporation stock issued during period, value, employee stock purchase plan for the quarter ending 2022-06-30 was $0.00.
- Quanterix Corporation stock issued during period, value, employee stock purchase plan for fiscal 2022 was $881.00K, a 17.28% decline from fiscal 2021.
- Quanterix Corporation stock issued during period, value, employee stock purchase plan for fiscal 2021 was $1.06M, a 19.93% increase from fiscal 2020.
- Quanterix Corporation stock issued during period, value, employee stock purchase plan for fiscal 2020 was $888.00K, a 1.14% increase from fiscal 2019.
- Quanterix Corporation stock issued during period, value, employee stock purchase plan for fiscal 2019 was $878.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2023-03-31 | $551.00K 10-Q · filed 2023-05-09 | $838.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $881.00K 10-K · filed 2023-03-06 |
| 2022-09-30 | $287.00K 10-Q · filed 2022-11-09 | $881.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.14M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-03-31 | $594.00K 10-Q · filed 2023-05-09 | $1.14M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $1.06M 10-K · filed 2023-03-06 |
| 2021-09-30 | $546.00K 10-Q · filed 2022-11-09 | $1.06M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $967.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $519.00K 10-Q · filed 2022-05-10 | $967.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $888.00K 10-K · filed 2023-03-06 |
| 2020-09-30 | $448.00K 10-Q · filed 2021-11-04 | $967.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $925.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $440.00K 10-Q · filed 2021-05-06 | $990.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $878.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $406.00K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $65.00K 10-Q · filed 2020-08-04 | |
| 2019-03-31 | $328.00K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |